Anders Bjartell
221 – 230 of 346
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Tumour markers in prostate cancer III: Biomarkers in urine
(
- Contribution to journal › Scientific review
-
Mark
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Role of histopathology and molecular markers in the active surveillance of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients
(
- Contribution to journal › Article
-
Mark
Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.
(
- Contribution to journal › Article
-
Mark
Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
(
- Contribution to journal › Article
-
Mark
The Contemporary Concept of Significant Versus Insignificant Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
CRISP-3 AND B-MSP ON PROSTATE CANCER NEEDLE-BIOPSIES DO NOT HAVE PREDICTIVE VALUE FOR SUBSEQUENT PROSTATECTOMY OUTCOME
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.237-238(
- Contribution to journal › Published meeting abstract
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
(
- Contribution to journal › Article